Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|17|1|19-31

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.17, Iss.1, 2017-06, pp. : 19-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Hot and Potential Targets of Type 2 Diabetes Mellitus Treatment in Recent Decade

By  

Current Drug Targets, Vol. 19, Iss. 1, 2018-01 ,pp. : 55-69

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Antidiabetic Agents: Current Role in Type 2 Diabetes Mellitus

By Krentz Andrew J.  

Drugs, Vol. 65, Iss. 3, 2005-01 ,pp. : 385-411

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of oral hypoglycaemic agents for the treatment of type 2 diabetes mellitus

By Ward Alexandra   O’Brien Judith A   Salas Maribel  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 601-608

Informa Healthcare

Access to resources Recommend Favorite

The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3665-3674

Bentham Science Publishers

Access to resources Recommend Favorite

Corrigendum: The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update

By  

Current Pharmaceutical Design, Vol. 21, Iss. 24, 2015-01 ,pp. : 3565-3565

Bentham Science Publishers

Access to resources Recommend Favorite